Windlas Biotech Limited — Others, 08-04-2025: Certificate under SEBI (Depositories and Participants) Regulations, 2018

Windlas Biotech Limited has announced a board meeting regarding the Certificate from MUFG Intime India Private Limited, confirming that no demat requests were processed during the quarter ended March 31, 2025. The absence of demat requests indicates that the company operates without any physical shares, streamlining operations and enhancing shareholder management. This update may positively influence investor sentiment by reflecting operational efficiency. Investors could view the situation as a stable aspect of the company's governance, possibly contributing to a positive outlook on shareholder interests.